Carthera has received an orphan medical device status endorsement for its SonoCloud ultrasound system for treating brain ...

InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) ...

It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...

Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...

Escala Medical has pulled in €4.5m ($5.3m) to drive market expansion of its Mendit device for women with pelvic organ ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...